We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.56B
AUM Growth
-$29.8M
Cap. Flow
-$341K
Cap. Flow %
-0.02%
Top 10 Hldgs %
25.81%
Holding
3,122
New
704
Increased
853
Reduced
892
Closed
464

Sector Composition

Rank Sector Weight
1 Technology 5.41%
2 Financials 3.2%
3 Healthcare 2.44%
4 Consumer Discretionary 2.3%
5 Industrials 1.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTR icon
1151
Ventas
VTR
$47.3B
$28.9K ﹤0.01%
420
-389
-48% -$24.8K
ELAN icon
1152
Elanco Animal Health
ELAN
$12.1B
$28.8K ﹤0.01%
2,741
-2,212
-45% -$25K
BLDR icon
1153
Builders FirstSource
BLDR
$7.8B
$28.7K ﹤0.01%
230
-1,424
-86% -$207K
JBL icon
1154
Jabil
JBL
$36.1B
$28.7K ﹤0.01%
211
-311
-60% -$47.8K
SLGN icon
1155
Silgan Holdings
SLGN
$4.39B
$28.6K ﹤0.01%
560
-187
-25% -$9.8K
AVDV icon
1156
Avantis International Small Cap Value ETF
AVDV
$19.5B
$28.6K ﹤0.01%
+410
New +$27.8K
SHOE
1157
Shoe Station Group
SHOE
$425M
$28.6K ﹤0.01%
1,300
-131
-9% -$3.31K
NMRK icon
1158
Newmark Group
NMRK
$2.66B
$28.5K ﹤0.01%
2,338
+735
+46% +$9.81K
RVTY icon
1159
Revvity
RVTY
$12.7B
$28.4K ﹤0.01%
268
+49
+22% +$5.65K
SLM icon
1160
SLM Corp
SLM
$5.15B
$28.3K ﹤0.01%
965
+51
+6% +$1.49K
BG icon
1161
Bunge Global
BG
$20.9B
$28.2K ﹤0.01%
369
+362
+5,171% +$27.1K
BIO icon
1162
Bio-Rad Laboratories Class A
BIO
$9.16B
$28K ﹤0.01%
115
+92
+400% +$27.7K
HQY icon
1163
HealthEquity
HQY
$8.65B
$27.7K ﹤0.01%
314
+264
+528% +$27.1K
AFG icon
1164
American Financial Group
AFG
$12.2B
$27.6K ﹤0.01%
210
+27
+15% +$3.49K
IEI icon
1165
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$27.5K ﹤0.01%
233
-8,166
-97% -$951K
FRI icon
1166
First Trust S&P REIT Index Fund
FRI
$195M
$27.5K ﹤0.01%
+1,000
New +$27.7K
GTM
1167
ZoomInfo Technologies
GTM
$1.22B
$27.5K ﹤0.01%
2,751
-5,690
-67% -$59.7K
EWJ icon
1168
iShares MSCI Japan ETF
EWJ
$22.5B
$27.5K ﹤0.01%
+401
New +$27.6K
RYTM icon
1169
Rhythm Pharmaceuticals
RYTM
$7.72B
$27.4K ﹤0.01%
518
+64
+14% +$3.55K
EQR icon
1170
Equity Residential
EQR
$25B
$27.3K ﹤0.01%
382
+21
+6% +$1.48K
RSPU icon
1171
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$527M
$27.3K ﹤0.01%
392
EEM icon
1172
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$27.3K ﹤0.01%
+624
New +$27.1K
XHS icon
1173
State Street SPDR S&P Health Care Services ETF
XHS
$203M
$27.2K ﹤0.01%
+277
New +$27.1K
WTAI icon
1174
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$652M
$27.1K ﹤0.01%
1,428
WIX icon
1175
WIX.com
WIX
$2.55B
$27.1K ﹤0.01%
+166
New +$34.5K

Similar funds

Arax Advisory Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Arax Advisory Partners held 3,122 positions worth $1.56B, down 1.9% from $1.59B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners's Q1 2025 filing shows 704 new, 853 increased, 892 reduced and 464 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M. The largest sale was Dimensional Core Fixed Income ETF, an estimated $25.2M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.9% a quarter earlier, followed by Financials and Healthcare.

  • Arax Advisory Partners's largest Q1 2025 buy was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M.
  • Arax Advisory Partners added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $21.8M increase.
  • Arax Advisory Partners's biggest Q1 2025 reduction was Dimensional Core Fixed Income ETF, cutting an estimated $25.2M.
  • Arax Advisory Partners fully exited Berkshire Hathaway Class B in Q1 2025, selling an estimated $1.03M.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.56B portfolio in Q1 2025.
  • Arax Advisory Partners opened 704 new positions and closed 464 in Q1 2025.
  • Arax Advisory Partners's portfolio value fell 1.9% quarter-over-quarter to $1.56B.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.